SPRIM Global Investments and OneIM Announce $300mn Joint Venture

SPRIM Global Investments („SGI“), a global investment firm specializing in clinical-stage life sciences and pharma services based in Singapore, and One Investment Management („OneIM“), a global alternative investment management firm, today announce a 0mn Joint Venture („JV“) to accelerate clinical trial financing.

The strategic partnership will fuel the expansion of SGI’s specialized financing platform, TrialCap, a pioneering financing solution designed to support clinical trials from Phase 1 through Phase 3. With more than two decades of deep industry expertise, TrialCap offers flexible and innovative financial support to biotech and medtech companies, helping them advance groundbreaking therapies and accelerate time-to-market.